Nivea Shares Her Leukemia Diagnosis—and Her Plans to Keep Creating

Nivea is speaking publicly about a deeply personal health challenge while making clear that her creative life is continuing.

The Grammy-nominated R&B singer revealed that she was diagnosed with chronic myeloid leukemia, commonly known as CML, in early 2026. She said the diagnosis was confirmed after two bone-marrow biopsy procedures and that treatment has been progressing well.

Nivea discussed the diagnosis during an appearance on Cadillac Chronicles, describing the experience as a major change in perspective.

Rather than centering the conversation entirely on fear, she emphasized gratitude, family and taking advantage of opportunities that remain available. She has not publicly provided a complete prognosis, and coverage should not speculate beyond the details she chose to disclose.

The singer also discussed returning to music and studying audio engineering, with particular interest in developing her understanding of mixing.

That detail is significant because it presents Nivea’s next chapter as more than a return to the microphone. Technical training can give an artist additional control over vocal production, recording decisions and the final presentation of her music.

Nivea became widely recognized during the early 2000s through songs including “Don’t Mess With My Man” and “Laundromat,” as well as her appearance on Mystikal’s “Danger (Been So Long).” Her solo career placed her inside an R&B era defined by strong vocal identities, memorable collaborations and a close relationship between radio, music television and physical singles.

A return now would place her in a very different industry.

Contemporary R&B artists can release music independently, communicate directly with listeners and build audiences around live performance, social video and catalog rediscovery. Nivea’s earlier records already circulate among listeners revisiting 2000s R&B, creating an audience bridge between longtime supporters and younger fans discovering the era.

Public support spread across Instagram and Threads after the disclosure. Those reactions show the depth of affection surrounding Nivea, but the foundation of the story remains her own interview and subsequent confirmation that the diagnosis is CML.

Her health should not become a promotional device.

The most respectful approach is to allow Nivea to define what she wishes to share while recognizing that her interest in engineering and recording represents an important creative development on its own.

PowerPage Analysis

Nivea’s story is about health, but it is also about artistic agency.

Studying audio engineering could give her greater control over how her voice is recorded and mixed at a point when she is reentering the industry with a clearer understanding of what matters to her.

Future coverage should follow her confirmed music plans without turning every professional update into an extension of her diagnosis.